SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Joe E. who wrote (2573)10/30/1997 1:41:00 PM
From: Randy Schmid  Read Replies (1) of 6136
 
Right you are, Joe. And my 55s are a little too out of the money. I also own Feb 50s which I'm letting stand - out of the money by about 15% currently - got em pretty cheap. So the overall position in Feb is pretty bullish. Holding off on doing anything with the Mays - still have plenty of time to decide, and who knows, announcements may give things a boost.

Just successfully (almost) rolled down. I owned Feb. 55s - sold em at 3 1/4, then bought Feb. 45s at 6 5/8, then sold Feb 55s again (to open) at 3 1/4. Not quite even money exchange, but at 1/8th point difference w/o commission cost included, I'll take it. FWIW, got the 55s back a while ago when the stock was at about 53.5, they cost me 7 3/8; Thus if AGPH is over 55 at expiry in Feb, I can still make 2 5/8 on the spread, or about 30+ % at maximum. Better than nothing!
Hope I'm proved horribly wrong to the upside!

Regards,

Randy
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext